SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2023 of Rs. 8001.00 millions grew by 9.76 % from Rs. 7289.40 millions.Net Profit recorded in the quarter ended December 2023 rise to 26.39% to Rs. 1279.20  millions  compared to R. 1012.10 millions in corresponding previous quarter.The company reported a good operating profit of 2213.00 millions compared to 1726.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 8001.00 7289.40 9.76 24894.40 21850.30 13.93 28841.60 21898.80 31.70
Other Income 66.10 31.10 112.54 185.80 53.40 247.94 86.50 386.10 -77.60
PBIDT 2213.00 1726.00 28.22 7029.40 5086.00 38.21 6733.40 5475.20 22.98
Interest 115.20 86.50 33.18 321.90 220.40 46.05 343.10 49.50 593.13
PBDT 2097.80 1639.50 27.95 6707.50 4865.60 37.86 6390.30 5425.70 17.78
Depreciation 333.70 280.40 19.01 955.20 814.40 17.29 1119.90 712.80 57.11
PBT 1764.10 1359.10 29.80 5752.30 4051.20 41.99 5270.40 4712.90 11.83
TAX 484.90 347.00 39.74 1577.20 1049.00 50.35 1381.50 1102.90 25.26
Deferred Tax 135.80 210.50 -35.49 401.50 439.00 -8.54 548.00 -122.10 -548.81
PAT 1279.20 1012.10 26.39 4175.10 3002.20 39.07 3888.90 3610.00 7.73
Equity 155.00 154.70 0.19 155.00 154.70 0.19 154.80 154.60 0.13
PBIDTM(%) 27.66 23.68 16.81 28.24 23.28 21.31 23.35 25.00 -6.62

JB Chem & Pharma Share Price

1978.00 -20.65 (-1.03%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×